Literature DB >> 23676573

Characteristics of anaphylaxis in children referred to a tertiary care center.

Emine Vezir1, Mustafa Erkoçoğlu, Ayşenur Kaya, Müge Toyran, Celal Özcan, Ayşegül Akan, Dilek Azkur, Tayfur Giniş, Ersoy Civelek, Can Naci Kocabaş.   

Abstract

Anaphylaxis is a potentially life-threatening condition. There are limited data about the etiology and the clinical characteristics in developing countries. This study aimed to investigate the clinical characteristics of anaphylaxis patients attending our pediatric allergy clinic. We conducted a prospective analysis of patients who were admitted to our allergy clinic for anaphylaxis from 2010 to 2012. Ninety-six patients were evaluated during the study period. The mean age was 7.4 ± 5.2 years. Venom, food, and drugs were the most common causative agents responsible for 31 (32.3%), 30 (31.3%), and 26 (27.1%) of the cases, respectively. Foods implicated most frequently were peanuts and nuts (n = 9; 30.0%), cow's milk (n = 7; 23.3%), and egg white (n = 6; 20.0%). The clinical manifestations during anaphylaxis in order of frequency were cutaneous (97.9%), respiratory (86.5%), gastrointestinal (42.7%), neurological (37.5%), and cardiovascular symptoms (30.2%). A biphasic course was noticed in five cases (5.2%). Of the 91 patients, 79 (86.8%) received H1-antihistamines, 73 (80.2%) received corticosteroids, 40 (44.4%) received adrenaline, 38 (41.8%) received fluid replacement therapy, 18 (19.8%) received β2-mimetics, and 8 (8.8%) received H2-antihistamines. According to severity, 7.3% of patients had mild, 59.4% had moderate, and 33.3% had severe anaphylaxis. Food and bee venom allergy were the most common etiologies. Adrenaline, the first-line treatment of anaphylaxis, was administered in only 44.4% of our cases.

Entities:  

Mesh:

Year:  2013        PMID: 23676573     DOI: 10.2500/aap.2013.34.3654

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  5 in total

Review 1.  The Epidemiology of Anaphylaxis.

Authors:  Joyce E Yu; Robert Y Lin
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 2.  Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?

Authors:  A Matito; M Carter
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

3.  Global Trends in Anaphylaxis Epidemiology and Clinical Implications.

Authors:  Paul J Turner; Dianne E Campbell; Megan S Motosue; Ronna L Campbell
Journal:  J Allergy Clin Immunol Pract       Date:  2019-11-28

4.  Global patterns in anaphylaxis due to specific foods: A systematic review.

Authors:  Alessia Baseggio Conrado; Nandinee Patel; Paul J Turner
Journal:  J Allergy Clin Immunol       Date:  2021-05-01       Impact factor: 10.793

5.  Epidemiology of anaphylaxis and biphasic reaction in Japanese children.

Authors:  Kento Ikegawa; Emi Morikawa; Ayako Nigo; Hiroshi Hataya; Akira Akasawa
Journal:  Acute Med Surg       Date:  2021-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.